IP Transactions Counsel Speaks on Panel at Life Sciences IP Due Diligence Webinar

March 3, 2020

IP transactions counsel Ryan Murphey (New York) will speak at a panel on “Implications of Recent Decisions, Legislation, PTO Guidance on Diligence Analysis” at a Strafford Publishing webinar on March 3.

The panel will address the implications of recent court decisions on the IP due diligence process in life sciences, current and pending legislation related to patent rights that impact life sciences analyses, and how counsel should address IP ownership questions that arise during due diligence.

Panel participants include Dana-Farber Cancer Institute chief intellectual property counsel Hilary Libka, Finnegan and Henderson partner Tom Irving and Knowles IP Strategies principal Sherry Knowles.